Oric Pharmaceuticals (ORIC) Interest Coverage Ratio (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Interest Coverage Ratio of 0.4 for Q1 2026, up 12.9% on a QoQ basis from 0.46 in Q3 2025, and up 85.73% year-over-year from 0.21 in Q1 2025.
Oric Pharmaceuticals (ORIC) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 0.4 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 85.73% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.51 (up 87.95% YoY) and the FY2025 annual result came in at 0.67, up 18.77% from the prior year.
- Interest Coverage Ratio was 0.4 for Q1 2026 at Oric Pharmaceuticals, up from 0.46 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.23 in Q4 2024 and bottomed at 143.63 in Q4 2022.
- A 5-year average of 10.99 and a median of 1.2 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio tumbled 2805.79% — and 2023, when it jumped 99.84%.
- Oric Pharmaceuticals' Interest Coverage Ratio stood at 143.63 in 2022, then soared by 99.84% to 0.24 in 2023, then advanced by 2.98% to 0.23 in 2024, then plunged by 99.16% to 0.46 in 2025, then advanced by 12.9% to 0.4 in 2026.
- Business Quant data shows ORIC's Interest Coverage Ratio at 0.4 in Q1 2026, 0.46 in Q3 2025, and 0.69 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | -0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.40 |
| Sep 30, 2025 | -0.46 |
| Jun 30, 2025 | -0.69 |
| Mar 31, 2025 | -2.79 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | -0.74 |
| Jun 30, 2024 | -1.56 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -1.88 |
| Jun 30, 2023 | -0.85 |
| Mar 31, 2023 | -1.99 |
| Dec 31, 2022 | -143.63 |
| Sep 30, 2022 | -11.23 |
| Jun 30, 2022 | -4.65 |
| Mar 31, 2022 | -4.24 |
| Dec 31, 2021 | -57.01 |
| Sep 30, 2021 | -0.39 |
| Jun 30, 2021 | -0.58 |
| Mar 31, 2021 | -0.27 |